Kontogeorgos Silvana, Sandström Tatiana Zverkova, Rosengren Annika, Fu Michael
Department of Molecular and Clinical Medicine/Cardiology, Sahlgrenska Academy, University of Gothenburg, Sahlgrenska University Hospital/Östra Hospital, Gothenburg, Sweden.
Department of Clinical Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
ESC Heart Fail. 2023 Oct;10(5):2973-2981. doi: 10.1002/ehf2.14474. Epub 2023 Jul 30.
The impact of hospital readmissions on the outcomes of heart failure (HF) patients is well known. However, data on temporal trends of cause-specific hospital readmissions in these patients are limited.
From 1987 to 2014, we identified and followed up for 1 year 608 135 patients ≥18 years hospitalized with HF according to the International Classification of Diseases (ICD) 9 and 10 from the National Inpatient Register. Readmissions for cardiovascular (CVD) and non-CVD causes and co-morbidities were defined according to ICD-9 and ICD-10 codes. We analysed trends in the incidence rate of readmissions, the median time to the first rehospitalization, and the time to readmission, stratified by sex, age groups and cause of rehospitalization using linear regression. During our study, 1 year all-cause mortality decreased (β = -4.93, P < 0.0001), but the incidence rate of readmissions per 1000 person-years remained unchanged. The readmission rate for CVD causes decreased; in contrast, the readmission rate increased across all age and sex groups for non-CVD causes. Analysing the patients by study periods (1987-1997, 1998-2007 and 2008-2014), CVD and non-CVD co-morbidities had a statistically significant increasing trend (P < 0.001). The median time in hospital decreased and the median time to the first readmission were almost unchanged.
Contrary to a declining mortality rate, the incidence rate of readmissions saw no change, possibly because of divergent trends in cause-specific readmissions. An increasing rate of readmissions for non-CVD causes underscores the importance of optimising multimorbidity management to reduce the risk of readmissions in patients with HF.
医院再入院对心力衰竭(HF)患者结局的影响已广为人知。然而,关于这些患者特定病因医院再入院时间趋势的数据有限。
1987年至2014年,我们从国家住院患者登记处根据国际疾病分类(ICD)9和10识别并随访了608135名≥18岁因HF住院的患者1年。心血管(CVD)和非CVD病因及合并症的再入院根据ICD - 9和ICD - 10编码进行定义。我们使用线性回归分析了再入院发生率、首次再住院的中位时间以及再入院时间的趋势,按性别、年龄组和再住院原因分层。在我们的研究期间,1年全因死亡率下降(β = -4.93,P < 0.0001),但每1000人年的再入院发生率保持不变。CVD病因的再入院率下降;相反,非CVD病因在所有年龄和性别组中的再入院率均上升。按研究时间段(1987 - 1997年、1998 - 2007年和2008 - 2014年)分析患者,CVD和非CVD合并症有统计学显著的上升趋势(P < 0.001)。住院中位时间缩短,首次再入院的中位时间几乎不变。
与死亡率下降相反,再入院发生率没有变化,可能是由于特定病因再入院趋势不同。非CVD病因的再入院率上升凸显了优化合并症管理以降低HF患者再入院风险的重要性。